Bionano Genomics Inc (BNGO) Is Now En Route to Higher Prices

Bionano Genomics Inc (NASDAQ: BNGO) is -31.22% lower on its value in year-to-date trading and has touched a low of $1.04 and a high of $16.30 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNGO stock was last observed hovering at around $1.23 in the last trading session, with the day’s gains setting it 0.07%.

Currently trading at $1.30, the stock is 6.47% and -12.83% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.78 million and changing 5.69% at the moment leaves the stock -64.87% off its SMA200. BNGO registered -91.72% loss for a year compared to 6-month loss of -67.42%. The firm has a 50-day simple moving average (SMA 50) of -$0.10 and a 200-day simple moving average (SMA200) of $0.02.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

The stock witnessed a -8.45% gain in the last 1 month and extending the period to 3 months gives it a -2.26%, and is 19.27% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.93% over the week and 8.21% over the month.

Profit margin for the company is -676.22%. Distance from 52-week low is 25.00% and -92.02% from its 52-week high. The company has generated returns on investments over the last 12 months (-179.41%).

Bionano Genomics Inc quarterly earnings per share for the current quarter are estimated at -$0.87 with sales reaching $10.58M over the same period.The EPS is expected to shrink by -43.74% this year, but quarterly earnings will post 29.40% year-over-year. Quarterly sales are estimated to grow 28.80% in year-over-year returns.

Bionano Genomics Inc (BNGO) Top Institutional Holders

71 institutions hold shares in Bionano Genomics Inc (BNGO), with institutional investors hold 11.86% of the company’s shares. The shares outstanding are 38.84M, and float is at 38.16M with Short Float at 14.68%. Institutions hold 11.79% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 1.45 million shares valued at $0.89 million. The investor’s holdings represent 4.11% of the BNGO Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 0.61 million shares valued at $0.37 million to account for 1.74% of the shares outstanding. The other top investors are Qube Research & Technologies Ltd which holds 0.39 million shares representing 1.11% and valued at over $0.24 million, while State Street Corporation holds 1.09% of the shares totaling 0.38 million with a market value of $0.23 million.

Bionano Genomics Inc (BNGO) Insider Activity

A total of 0 insider transactions have happened at Bionano Genomics Inc (BNGO) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider purchase by Mamuszka Hannah,the company’sDirector. SEC filings show that Mamuszka Hannah bought 65,789 shares of the company’s common stock on Jun 13 at a price of $0.76 per share for a total of $50000.0. Following the purchase, the insider now owns 65789.0 shares.

Bionano Genomics Inc disclosed in a document filed with the SEC on May 16 that Holmlin R. Erik (President and CEO) bought a total of 15,000 shares of the company’s common stock. The trade occurred on May 16 and was made at $0.64 per share for $9639.0. Following the transaction, the insider now directly holds 0.81 million shares of the BNGO stock.

Still, SEC filings show that on May 12, Stewart Christopher P. (Chief Financial Officer) acquired 50,000 shares at an average price of $0.67 for $33415.0. The insider now directly holds 281,373 shares of Bionano Genomics Inc (BNGO).